Holen Sie sich die Stockscreener-App
63.24
2.10%
1.30
Schlusskurs vom Vortag:
$61.94
Offen:
$62.25
24-Stunden-Volumen:
2.23M
Relative Volume:
1.00
Marktkapitalisierung:
$9.64B
Einnahmen:
$3.46B
Nettoeinkommen (Verlust:
$-9.40M
KGV:
-263.06
EPS:
-0.2404
Netto-Cashflow:
$51.30M
1W Leistung:
-1.46%
1M Leistung:
+7.15%
6M Leistung:
+72.03%
1J Leistung:
+81.57%
1-Tages-Spanne:
$62.25
$64.36
1-Wochen-Bereich:
$61.70
$66.98
52-Wochen-Spanne:
$32.37
$66.98
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
63.24 | 9.78B | 3.46B | -9.40M | 51.30M | -0.2404 |
ABT
Abbott Laboratories
|
97.50 | 168.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker Corporation stock hits 52-week high at 65.48 USD - Investing.com
Bruker Corporation (BRKR) Stock Price, News, Quote & History - Yahoo! Finance Canada
Bruker Corporation (BRKR) stock price, news, quote and history - uk.finance.yahoo.com
Bruker Corporation Announces New Timsultra Aip and Timsomni Workflows for Drug Discovery and Development and Disease Biology Research - marketscreener.com
Bruker unveils proteomics workflows at HUPO congress - Investing.com
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research - Yahoo Finance
Bruker Sees AI-Fueled Semiconductor Demand, Targets Critical Q4 Revenue Rebound - Yahoo Finance
Arm leads Wednesday's losers with an 8.5% drop as Bruker tops the gainers - 24/7 Wall St.
A Look at Bruker Corp (BRKR) After 7.3% Gain -- GF Value $60.34 vs Price $64.00 - GuruFocus
Bruker Corporation (BRKR) Stock Forecasts - Yahoo! Finance Canada
Bruker (NASDAQ:BRKR) Raised to "Strong-Buy" at The Goldman Sachs Group - MarketBeat
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Bruker at Bank of America Global Healthcare Conference: growth mix lifts outlook - Investing.com
Is Bruker (BRKR) Using Flagship Academic NMR Deals To Deepen Its High-End Moat? - Yahoo Finance
Bruker Corporation Receives Order from University of California, Berkeley for High-Field Nmr Systems for Major Upgrade of Magnetic Resonance Research Infrastructure - marketscreener.com
Bruker Gets More Than $6 Million Order From University of California, Berkeley - marketscreener.com
UC Berkeley orders NMR equipment from Bruker for over $6M - Investing.com
UC Berkeley orders more than $6 million in research equipment from Bruker - Stock Titan
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley - marketscreener.com
Bruker Corporation (NASDAQ:BRKR) Plans Quarterly Dividend of $0.05 - MarketBeat
Bruker Stock Price Forecast. Should You Buy BRKR? - StockInvest.us
Tidal Investments LLC Has $1.75 Million Stake in Bruker Corporation $BRKR - MarketBeat
BRUKER CORP Insider Munch Mark Executes 2,000 Options at $22.19 and Sells Shares at $52.87 - Kalkine Media
Bruker Corporation at Morgan Stanley Global Healthcare Conference Transcript - GuruFocus
Bruker at Morgan Stanley conference: betting on post-genomic growth - Investing.com
Bruker (BRKR) EVP sells 2,000 shares under trading plan - Stock Titan
Bruker Corp (BRKR) Stock Up 5.8% and Still Undervalued -- GF Sco - GuruFocus
Bruker (NASDAQ: BRKR) officer to sell 2,000 shares - Stock Titan
Bruker Corporation (NASDAQ:BRKR) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
55,937 Shares in Bruker Corporation $BRKR Purchased by Squarepoint Ops LLC - MarketBeat
Bruker Corporation at Wells Fargo Healthcare Conference Transcript - GuruFocus
Wellington Management Group LLP Invests $1.36 Million in Bruker Corporation $BRKR - MarketBeat
Can Bruker (BRKR) Stay Below Fair Value After Fusion News? - simplywall.st
Bruker Corp (BRKR) Shares Fall 6.8% -- What GF Score of 86 Tells Investors - GuruFocus
UBS Adjusts Bruker Price Target to $65 From $45, Maintains Neutral Rating - Moomoo
Why Bruker (BRKR) Stock Is Falling Today - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Down 7.1%Time to Sell? - MarketBeat
UBS Group Begins Coverage on Bruker (NASDAQ:BRKR) - MarketBeat
Bruker at Wells Fargo Healthcare Conference: deep tech drives growth - Investing.com
Bruker Corporation to Present at Upcoming Investor Conferences - Yahoo Finance
NanoString Technologies: Litigation-Driven 363 Sale and $392.6M Bruker Acquisition - ElevenFlo
Bruker (BRKR) Wagers On Fusion Energy While Wall Street Waits - Yahoo Finance
Bruker Corporation (BRKR) Peer Comparison – Compare with Others - Value Research
Bruker (NASDAQ:BRKR) Downgraded by Zacks Research to Hold - MarketBeat
Bruker, Luvata Collaborating on Supply of Superconductors for Magnetic Confinement Fusion - marketscreener.com
Fusion plasma is hotter than the sun’s core. Bruker and Luvata will work to expand special wire supplies. - Stock Titan
Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report? - finance.yahoo.com
A Look at Bruker Corp (BRKR) After 3.4% Decline -- GF Value $60. - GuruFocus
List of 44 Acquisitions by Bruker (Sep 2026) - Tracxn
Deutsche Bank AG Invests $1.44 Million in Bruker Corporation $BRKR - MarketBeat
A Look at Bruker Corp (BRKR) After 3.7% Decline -- GF Value $60. - GuruFocus
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Bruker Corp-Aktie (BRKR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. |
Sep 15 '26 |
Sale |
52.87 |
2,000 |
105,740 |
134,806 |
0.26%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):